Hetero Labs Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HETERO LABS LTD, and what generic and branded alternatives to HETERO LABS LTD drugs are available?
HETERO LABS LTD has one hundred and thirty-eight approved drugs.
There are seven tentative approvals on HETERO LABS LTD drugs.
Summary for Hetero Labs Ltd
| US Patents: | 0 |
| Tradenames: | 115 |
| Ingredients: | 113 |
| NDAs: | 138 |
| Drug Master File Entries: | 115 |
| Patent Litigation for Hetero Labs Ltd: | See patent lawsuits for Hetero Labs Ltd |
Drugs and US Patents for Hetero Labs Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hetero Labs Ltd Iii | RUFINAMIDE | rufinamide | TABLET;ORAL | 204993-002 | May 11, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hetero Labs Ltd Iii | LORATADINE | loratadine | SYRUP;ORAL | 210409-001 | May 7, 2021 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Hetero Labs Ltd Iii | RUFINAMIDE | rufinamide | SUSPENSION;ORAL | 216841-001 | Dec 5, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for HETERO LABS LTD drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
